2018 annual convention - aamri

2018 ANNUAL CONVENTION26 & 27 November Hyatt Hotel Canberra120 Commonwealth Ave, Yarralumla ACT 2600

2

AAMRI MEMBERS

EVENT CONTACTS

Peter Thomas, 0411 600 992, [email protected] Kathryn Naumenko, 0402 117 529, [email protected] Cath Latham, 0413 865 459, [email protected] Aimee Sanderson, 0414 611 334, [email protected]

WIFI ACCESS

Select network: @Hyatt_Wifi Option: Conference code Enter code: AAMRI18

mailto:[email protected]




3

CONVENTION PROGRAM MON 26 NOV

9.00am REGISTRATION OPENS 9.30am-12.30pm MRI BUSINESS MANAGERS’ MEETING

Federation Ballroom, Hyatt Hotel Canberra

Pages 7-13

12.30pm-1.30pm LUNCH

The Gallery, Hyatt Hotel Canberra

1.30pm-5.00pm AAMRI STRATEGY MEETING


Pages 14-20

5.00pm-6.00pm MRI BOARD MEMBER PRE-DINNER DRINKS

The Lavender Terrace, Hyatt Hotel Canberra

6.00pm Courtesy coaches from Hyatt Hotel Canberra to Parliament

House Depart from Kaye place, located at the rear of the Hyatt Hotel Canberra

6.30pm 2018 AAMRI ANNUAL DINNER

Great Hall, Parliament House Guest speaker: The Hon Catherine King MP, Shadow Minister for Health and Medicare

10.15PM Courtesy coach from Parliament House to Hyatt Hotel

Canberra

TUE 27 NOV

7.20am-8.30am AAMRI PRESIDENT’S BREAKFAST Federation Ballroom North, Hyatt Hotel Canberra Guest speaker: The Hon Greg Hunt MP, Minister for Health

9.00am-11.00am AAMRI AGM (REGISTRATION FROM 8.30AM)

Federation Ballroom North, Hyatt Hotel Canberra

Pages 21-61

4

PARTICIPANTS Mr Hughes Amoyal

COO Kolling Institute of Medical Research

Mr David Barda

Head of Business Development & Innovation

Garvan Institute of Medical Research

Ms Glenys Beauchamp PSM Secretary Department of Health

Prof David Berlowitz

Director Institute for Breathing and Sleep

Mrs Hilary Bolton

Deputy Director Administration Baker Heart and Diabetes Institute

Ms Leah Borsboom Head of People Development Centre for Eye Research Australia

Mr Matthew Browne

CEO Melanoma Institute Australia

Ms Lee Bruce

Director - Corporate Services Translational Research Institute

Prof Jonathan Carapetis AM Director Telethon Kids Institute

Prof John Carroll

Dean & Director Monash Biomedicine Discovery Institute

Assoc. Prof Aimee S. Catalan

Director of Operations Mater Research

Prof Jonathan Cebon

Medical Director Olivia Newton-John Cancer Research Institute

Mr Joel Chibert

CFO Walter and Eliza Hall Institute of Medical Research

Mr Philip Chronican Board Chair Designate The Westmead Institute for Medical Research

Ms Nicole Cockayne

Director Discovery and Innovation Black Dog Institute

Prof Alan Cowman

Deputy Director Science Strategy Walter and Eliza Hall Institute of Medical Research

Prof Brendan Crabb AC CEO and Director Burnet Institute

Mr David Craig

Deputy Chair Victor Chang Cardiac Research Institute

Prof Tony Cunningham AO Executive Director The Westmead Institute for Medical Research

Prof Peter Currie

Director Australian Regenerative Medicine Institute

Mr Russell D'Costa

Business Manager Centre for Cancer Biology

Mr John Dakin

COO The Westmead Institute for Medical Research

Ms Mardi Davis

Assistant Director Innovation and Science Australia

Dr Charles Day

CEO Innovation and Science Australia

Dr Henry De Aizpurua Deputy Director The Florey Institute for Neuroscience and Mental Health

Dr Nicole den Elzen Exec GM, Research Management & Strategy

Baker Heart and Diabetes Institute

Assoc. Prof Briony Dow

Director National Ageing Research Institute

Dr James Dromey

COO Murdoch Children's Research Institute

Prof Ashley Dunn

Member of the Board Olivia Newton-John Cancer Research Institute

Dr Marie Dziadek

Chief Scientific Officer Garvan Institute of Medical Research

Mr Bob Edgar

Board Chair Hudson Institute of Medical Research

Ms Joanne Elliot

COO Woolcock Institute of Medical Research

Prof Matthias Ernst

Scientific Director Olivia Newton-John Cancer Research Institute

Mr Robert Estcourt

Chair Woolcock Institute of Medical Research

Dr Robin Fieldhouse Head of Strategic Projects (Life Sciences)

John Curtin School of Medical Research

Mr Ross Flemons

Finance Manager Asbestos Diseases Research Institute

Ms Diana Forsyth

COO Harry Perkins Institute of Medical Research

Prof Ian Frazer AC President Australian Academy of Health and Medical Sciences

Ms Jackie Gambrell

Director Corporate Services Black Dog Institute

Mrs Dorota Gancarz

Quality Manager South Australian Health and Medical Research Institute

Prof Frank Gannon

Director and CEO QIMR Berghofer Medical Research Institute

Dr Carol Ginns

Associate Director Research Support & Development

Peter MacCallum Cancer Centre

Mr Marcus Goddard

Business Manager Robinson Research Institute

Mr Terry Goldacre

Chairman Ingham Institute

Prof Chris Goodnow Executive Director Garvan Institute of Medical Research

Mr Peter Gover

COO Bionics Institute

Prof Robert Graham

Executive Director Victor Chang Cardiac Research Institute

Ms Britt Granath

Head, Governance & Policy Victor Chang Cardiac Research Institute

Mr Matthew Grounds

Chairman Victor Chang Cardiac Research Institute

Ms Kate Gunn

COO Garvan Institute of Medical Research

Prof Michelle Haber AM Executive Director Children's Cancer Institute

Mr Graham Hall

Deputy Director & Head, Children's Lung Health

Telethon Kids Institute

Mr Darryl Harkness

CEO Ingham Institute

Dr Andrew Hastings

Manager, VicAAMRI AAMRI

Ms Jessica Henry

Strategy Implementation Consultant

Children's Cancer Institute

5

Mr Peter Hicks Business Manager Menzies Institute for Medical Research

Ms Olivia Hilton Chair Centre for Eye Research Australia

Prof Doug Hilton AO Walter and Eliza Hall Institute of Medical Research

Dr Stephen Hollings Heart Research Institute

Mr Richard Howard Hunter Medical Research Institute

Mr Laurence Iffla Harry Perkins Institute of Medical Research

Dr Kate Johnston Neuroscience Research Australia

Dr Anne Johnston St Vincent's Institute of Medical Research

Prof Ricky Johnstone Peter MacCallum Cancer Centre

Mr Peter Joseph AO Black Dog Institute

Ms Melissa Kaplan-Osborne

Microsoft

Assoc. Prof Greg Kaplan Ingham Institute

Prof Thomas Kay St Vincent's Institute of Medical Research

Ms Victoria Keena Asbestos Diseases Research Institute

Mr Robert Klupacs Bionics Institute

Dr Maree Knight Mater Research

Prof Sharad Kumar AM Centre for Cancer Biology

Ms Kelly Langdon Queensland Eye Institute

Dr Cath Latham AAMRI

Prof Peter Leedman Harry Perkins Institute of Medical Research

Prof Angel Lopez AO Centre for Cancer Biology

Miss Samantha Ludolf Walter and Eliza Hall Institute of Medical Research

Prof Robert Lusby AM ANZAC Research Institute

Prof David Mackey Lions Eye Institute

Prof Helen Marshall Robinson Research Institute

Prof Frank Martin AM Children's Medical Research Institute

Prof Christine McDonald AM Institute for Breathing and Sleep

Ms Clare McLaughlin Department of Industry, Innovation and Science

Mr Rory McQuillan Monash Biomedicine Discovery Institute

Mr Rob Merriel Hudson Institute of Medical Research

Mr John Moran Orygen, The National Centre of Excellence in Youth Mental Health

Ms Maxine Morand Peter MacCallum Cancer Centre

Ms Kathryn Naumenko AAMRI

Prof Kathryn North AM Murdoch Children's Research Institute

Mr Michael Nugent Kolling Institute of Medical Research

Ms Debra O'Connor National Ageing Research Institute

Dr Nick Pearce Centenary Institute of Cancer Medicine and Cell Biology

Dr Joseph Pereira Hudson Institute of Medical Research

Prof Vlado Perkovic The George Institute for Global Health

Prof Steven Petrou The Florey Institute for Neuroscience and Mental Health

Prof Rodney Phillips The George Institute for Global Health

Assoc. Prof Rosemary Purcell Orygen, The National Centre of Excellence in Youth Mental Health

Mr Tony Reeves St Vincent's Institute of Medical Research

Mr Tim Regan The George Institute for Global Health

Dr Georgia Rekaris Hinton Victor Chang Cardiac Research Institute

Mr Blake Repine Menzies School of Health Research

Mr Jon Rhoades St Vincent's Institute of Medical Research

Ms Kelly Rodger AAMRI

Ms Aimee Sanderson AAMRI

Ms Sieglind Schmidmaier Peter MacCallum Cancer Centre

Prof Peter Schofield Neuroscience Research Australia

Ms Veronica Scott MinterEllison

Mr Peter Scott Baker Heart and Diabetes Institute

Mr Mark Sheridan

Director

CEO

General Manager Corporate Services Chairman

COO

Head Research Strategy

Executive Director Cancer Research Chair

Digital Transformation Advisor - Not for Profits COO

Director

Executive Officer

CEO

Acting CEO

Co-Director

COO

Policy & Project Officer

Director

Co-Director

Deputy Director, Strategy & Operations Chair of the Board

Managing Director

Senior Medical Proactitioner and Director, Vaccinology and Immumology Research Trials Unit President

IBAS Medical Director & Board Member General Manager

COO

CFO and Company Secretary

COO

Chair, Board of Directors

Event Coordinator

Director

Chair- Interim Management Committee Deputy Director

COO

Senior Operations Manager

Executive Director

Director

Director

Director, Research & Translation

Board Chair

COO

Director of Scientific Operations

COO

IT Manager

Event Assistant Marketing and Communications Manager Executive Director Strategy and Planning CEO

Special Counsel

Chairman

Chairman Queensland Eye Institute

6

Prof John Shine AC PresAA

President Australian Academy of Science

Mr Prad Somaiya

Financial Controller Neuroscience Research Australia

Prof Carolyn Sue

Interim Director Kolling Institute Kolling Institute of Medical Research

Dr Norman Swan

Broadcaster ABC Radio National

Mrs Julie Taranto

Research Operations Manager ANZAC Research Institute

Mr Mark Tennent

COO Burnet Institute

Dr Peter Thomas

Director of Policy and Operations AAMRI

Mr Christopher Thomas AM President Walter and Eliza Hall Institute of Medical Research

Dr Meena Thuraisingham Director The George Institute for Global Health

Ms Kim Tsai

COO/CFO Olivia Newton-John Cancer Research Institute

Prof Mathew Vadas AO Executive Director Centenary Institute of Cancer Medicine and Cell Biology

Dr Peter van Wijngaarden Interim Managing Director Centre for Eye Research Australia

Prof David Vaux AO Deputy Director Walter and Eliza Hall Institute of Medical Research

Prof Alison Venn

Director Menzies Institute for Medical Research

Mrs Mary Vukmirovic Research Manager Lions Eye Institute

Ms Yvette Waddell

CEO Brien Holden Vision Institute

Prof Tom Walley

Director Hunter Medical Research Institute

Mrs Lorraine Wallis

Head of Finance Children's Cancer Institute

Dr Peter Wejbora

Head Research Development & Partnerships

Children's Cancer Institute

Prof Steve Wesselingh Executive Director South Australian Health and Medical Research Institute

Mr Chris Whitelock COO Lions Eye Institute

Mr Nick Wood

CFO Telethon Kids Institute

7

MRI BUSINESS MANAGERS’ MEETING MONDAY 26 NOVEMBER, 9.00AM – 12.30PM

Federation Ballroom North, Hyatt Hotel Canberra Chair: Dr Cath Latham, AAMRI 9.00am REGISTRATION OPENS 9.30am WELCOME

Dr Cath Latham, AAMRI 9.35am

Understanding what digital transformation means for not for profits Meli Kaplan-Osborne, Digital Transformation Advisor, Microsoft

10.05am Protecting digital health research data and managing cyber risk

Veronica Scott, Special Counsel, MinterEllison 10.35am MORNING TEA

To be held in The Gallery 11.05am To be held in Federation Ballroom

North Research Data Management – research data storage and compliance with legislation Professor Marie Dziadek, Chief Scientific Officer, Garvan Institute of Medical Research

To be held in Federation Ballroom South Roundtable discussion Challenges and opportunities for hubs and university and hospital based MRIs Chair: Marcus Goddard, Business Manager, Robinson Research Institute

11.30am Designing and implementing risk

registers Dorota Gancarz, Quality Manager, South Australian Health and Medical Research Institute (SAHMRI)

12.00pm New funding models for MRIs

Yvette Waddell, Chief Executive Officer, Brien Holden Vision Institute

MRI BUSINESS MANAGERS’ MEETING

8

MELI KAPLAN-OSBORNE

Digital Transformation Advisor – Not for Profits Tech for Social Impact, Microsoft

UNDERSTANDING WHAT DIGITAL TRANSFORMATION MEANS FOR NOT FOR PROFITS Digital transformation is more than just a change of tools or technological devices. Daily practices, workplace structures, reporting relationships, information sharing, beneficiary and funder interaction, and even innovation are also transformed. We are moving from today's mobile-first, cloud-first world to a new world - one that is going to be made up of an intelligent cloud and an intelligent edge.

Meli will explain these fundamental aspects of the digital transformation age and how it differs from previous technological advances. She will outline how it opens up possibilities for organisations to engage donors and funders, empower employees, optimise operations and innovate for impact.

ABOUT MELI As the Digital Transformation Advisor, Melissa (Meli) assists Not for Profit leaders in imaging, envisioning and designing their future digital state. This is done through relationships with the CxOs, guiding them through established frameworks and methodologies and delivering transformation programs, in partnership with Microsoft, and partners to ensure successful outcomes. Her passion is as a digital transformation evangelist within Microsoft and the wider not for profit community.

Meli has over 20 years’ experience designing and implementing leading-edge digital and technology solutions and strategies across a wide range of clients in multiple industries and government, in Australia, the United States and Europe.

Since 2009 Meli has focused on the development and delivery of digital customer communication solutions. These solutions focus on ‘anywhere’ personalised messaging ensuring an engaging customer experience. Meli is passionate about digital and new media innovation. She has published papers on the application of digital technologies on the customer experience and the impact of digital on the future of information management. She has presented at multiple industry and technical forums on the application of new and future technologies to improve the customer experience.


9

VERONICA SCOTT

Special Counsel MinterEllison

PROTECTING DIGITAL HEALTH RESEARCH DATA AND MANAGING CYBER RISK Trust and security are critical to enabling the use of health data for research. This session aims to help research organisations understand and navigate the data protection regulatory framework that applies to health data, manage the privacy and security risks, respond to data security breaches and become more cyber resilient.

ABOUT VERONICA Veronica is Special Counsel in law firm MinterEllison and heads its National Privacy Group. She advises government, corporate and NGO clients on legal issues and risks in relation to all forms of data, content and communications. These include the protection of and rights in data, information privacy laws (including the European General Data Protection Regulation - GDPR), confidentiality, health records, research projects, marketing, tracking and surveillance laws, cyber and data security, cyber liability, data breach and crisis management. She helps clients respond to the opportunities and impact of digital disruption and technologies to develop strategies, policies and procedures in relation to data and data governance to ensure clients can meet their legal obligations, manage risk and innovate. Veronica has defended government agencies, the private sector and the media in reputationally sensitive claims including for defamation, breaches of confidence and of privacy. She is nominated as breach counsel for a number of cyber liability insurance products and regularly advises on sensitive data security breaches. Veronica holds a number of board positions with the Australian and New Zealand Association of Privacy Professionals (iappANZ), the Melbourne Press Club and ScriptWise Ltd. Veronica was on the Advisory Committee to the Australian Law Reform Council's inquiry into 'Serious invasions of privacy in the digital age'.


10

PROFESSOR MARIE DZIADEK

Chief Scientific Officer Garvan Institute of Medical Research

RESEARCH DATA MANAGEMENT – RESEARCH DATA STORAGE AND COMPLIANCE WITH LEGISLATION Marie will outline the information management processes that Garvan is establishing to protect personal and confidential data collected for research and other purposes. Her presentation will cover the following topics:

• data classification guidelines, implementation and education, • Information Technology policies, controls and security tools, • data storage, backup and retention policies; • data access management • internal monitoring of data access and system vulnerabilities • security incidents plan and data breach response plan.

ABOUT MARIE Marie is the Chief Scientific Officer at the Garvan Institute and in this role has responsibility for research governance and the Institute’s compliance with the Australian Code for Responsible Conduct of Research. She developed the policy framework for research management and research integrity at Garvan, including policies and processes for management of data and materials and transfer of these to other institutions. Marie led the consultation process for the selection of an Electronic Laboratory Notebook, and led the mandatory implementation of LabArchives at Garvan in 2015. She is part of a Working Group that is developing policies and guidelines to manage the security of personal and private information at Garvan, including human research data, to meet legislative requirements.


11

DOROTA GANCARZ

Quality Manager South Australian Health and Medical Research Institute

DESIGNING AND IMPLEMENTING RISK REGISTERS

Dorota will discuss SAHMRI’s journey in developing a risk management framework from the institute’s very beginning before the building was occupied, through everyday operations to the current expansion phase.

ABOUT DOROTA Dorota Gancarz is the Quality Manager at the South Australian Health and Research Institute (SAHMRI), where she provides necessary definition, development and deployment of SAHMRI’s quality assurance strategy and framework for its products and services. After achieving a Master’s degree in chemistry, Dorota moved to Australia and worked as a researcher in both the drug development and preclinical research spheres. She found herself interested in quality, risk and compliance matters and actively explored how she could contribute to the facilitation of research excellence in a risk and compliance role. Recently Dorota has steered the SAHMRI Research and Corporate teams to achieve ISO 9001 Quality Management System and ISO 27001 Information Security Management Systems certifications, as well as being instrumental in development and implementation of SAHMRI Business Continuity Framework. Working closely with Executive group and as a member of various institutional committees, Dorota helps to embed the SAHMRI culture of both excellence and integrity through the formulation of policies and plans which complement the desired behavioural values and SAHMRI strategic goals.

When not working, Dorota spends time with her young family. She loves sports, the great outdoors, horse riding and archery.

If you would like chat about any of the above (especially the latter) please contact Dorota at [email protected] or call 0433920113.



12

ROUNDTABLE DISCUSSION

Chair: Mr Marcus Goddard, Business Manager, Robinson Research Institute

CHALLENGES AND OPPORTUNITIES FOR HUBS AND UNIVERSITY AND HOSPITAL BASED MRIS

While all medical research institutes (MRIs) share much in common, hubs, university and hospital based MRIs have some unique opportunities and challenges. In this session, we will discuss topics particularly relevant to hubs, university and hospital based MRIs such as how institutes are structured, governed and financed within the context of hubs, universities and hospitals.

The intention of this session is that those participating will benefit from hearing about the different models and approaches to implementation and ways of managing challenges unique to hubs, university and hospital based MRIs.

AAMRI’S UNIVERSITY AND HOSPITAL BASED MEMBERS


13

YVETTE WADDELL

Chief Executive Officer Brien Holden Vision Institute

NEW FUNDING MODELS FOR MRIS Grants are a highly competitive environment in which to seek funds. The success rates for applications are low - 18.9% in 2018 for ARC Discovery Grants and 16.4% for NHMRC Project Grants in 2017 - while CRC-P applications require an industry led partner. It has become necessary for medical research institutes (and not for profit organisations) to look at other funding models in order to sustainably support their medical research and innovation. This can involve:

• Fee for service work or generating revenue from commercialisation i.e. licensing your technology or co-development technology with a partner.

• Joint Ventures and spin offs and the ability to share profit from these businesses. • Collaborative agreements “work with people that can do something quicker/smarter/better

than you” allowing you to get a sellable project sooner.

The Brien Holden Vision Institute has participated in two Cooperative Research Centre grants – CRC for Eye Research and Technology and the Vision CRC. The result of a successful collaboration was a commercially successful contact lens containing higher levels of oxygen, as well as water, both of which are essential for ocular health. The resultant IP and sales have been reinvested into research and innovation within the organisation. The collaboration also gave Brien Holden Vision Institute invaluable experience and confidence to pursue further collaborators. The Brien Holden Vision Institute has invested royalties it has received into further translational research and a PhD program. It also expanded its remit to include those who are vision impaired because they are unable to access an eye examination and pair of spectacles. Public health initiatives have resulted in:

• More than 12 million people in over 50 countries receiving an eye examination or pair of glasses;

• Helped train around 160,000 eye care personnel; • Supported 14 optometry schools to help build sustainable eye care systems.

ABOUT YVETTE Yvette Waddell is the CEO of Brien Holden Vision Institute. She was previously Chief Operating Officer (COO) at Brien Holden Vision Institute, leading the business development, finance, governance and risk functions that deliver the business’ strategic objectives.

Yvette was appointed COO of the Institute in 2003, following previous roles as General Manager and Executive Director. Since August 2015, while holding responsibility for operational support functions and infrastructure, Yvette has overseen commercialisation transactions and negotiations for Brien Holden Vision Institute. Yvette replaced Professor Brien Holden on the board of Brien Holden Vision Institute in July 2015 and holds group directorships in China and USA, including Optometry Giving Sight. Yvette is CEO of Vision CRC and was CEO of Viscorp Pty Ltd, the commercialisation company established to manage and commercialise intellectual property generated by Vision CRC programs.

Yvette is a graduate of the Australian Institute of Company Directors and was recognised as one of the most influential women in optical in 2016, by Vision Monday, a leading optical industry journal in the USA. She is a University of New South Wales Australia graduate, completing an MBA at AGSM at UNSW Business School.

AAMRI STRATEGY MEETING

MONDAY 26 NOVEMBER, 1.30PM – 5.00PM


Chair: Professor Tony Cunningham AO, AAMRI President

AGENDA 1.30pm Panel discussion

WHAT CAN MEDICAL RESEARCH ACHIEVE OVER THE NEXT 25 YEARS? Hosted by: Dr Norman Swan, ABC Radio National Health Report

Panellists: • Professor John Shine AC, President, Australian Academy of Science• Professor Kathryn North AM, Director, Murdoch Children’s Research

Institute• Glenys Beauchamp PSM, Secretary, Department of Health• Professor Ian Frazer AC, President, Australian Academy of Health and

Medical Sciences (AAHMS)• Dr Charlie Day, CEO, Innovation and Science Australia (ISA)

2.30pm CHANGING HEALTH POLICY THROUGH MEDICAL RESEARCH Glenys Beauchamp PSM, Secretary, Department of Health

2.55pm AFTERNOON TEA To be held in The Gallery

3.30pm A STRATEGIC OVERVIEW OF INNOVATION, SCIENCE AND RESEARCH IN AUSTRALIA’S HEALTH SECTOR Dr Charlie Day, CEO, Innovation and Science Australia

3.55pm WHAT NEXT FOR THE MEDICAL RESEARCH FUTURE FUND? Professor Ian Frazer AC, President, Australian Academy of Health and Medical Sciences (AAHMS)

4.20pm RESEARCH INTEGRITY AT MRIS: ISSUES AND RESPONSES Professor David Vaux AO, Walter and Eliza Hall Institute of Medical Research

4.40pm FROM FUNDAMENTAL RESEARCH TO CLINICAL CARE – THE PETER MAC CELLULAR IMMUNOTHERAPY CASE STUDY Professor Ricky Johnstone & Siegi Schmidmaier, Peter MacCallum Cancer Centre

5.00pm CLOSE


15

PANEL DISCUSSION

WHAT CAN MEDICAL RESEARCH ACHIEVE OVER THE NEXT 25 YEARS?

Hosted by Dr Norman Swan, ABC Radio National Health Report

Panellists

Professor John Shine AC, President, Australian Academy of Science

Professor Kathryn North AM, Director, Murdoch Children’s Research Institute

Glenys Beauchamp PSM, Secretary, Department of Health

Professor Ian Frazer AC, President, Australian Academy of Health and Medical Sciences

Dr Charlie Day, CEO, Office of Innovation and Science Australia

In the last few decades, new vaccines, diagnostics and drugs have transformed healthcare and mean that people are healthier and living longer. We’ve seen the global elimination of smallpox, death rates fall significantly for measles, malaria and other infectious diseases, and HIV has been transformed from a death sentence to a manageable life-long condition. None of it would have been possible without medical research, which has provided the tools to significantly reduce global disease burden – tools like new interventions, treatments, prevention options and research-led public health initiatives.

But what health challenges will we have to face over the next 20-30 years? How can medical research prepare us for these challenges? Large scale environmental changes and our expanding cities could drastically impact the health and well being of the population. Technological advances in health and society have the ability to radically change the way we manage and understand our health needs. And how can we prepare for the next big disease outbreak?

Our expert panellists will explore the potential health challenges on the horizon and how medical research can make sure we’re ready for anything the future could send our way.

PLEASE NOTE: this session will be recorded by ABC Radio National and broadcast on the Health Report, 26th November 2018.


16

GLENYS BEAUCHAMP PSM

Secretary Department of Health

CHANGING HEALTH POLICY THROUGH MEDICAL RESEARCH

ABOUT GLENYS Glenys Beauchamp was appointed Secretary of the Department of Health on 18 September 2017. Glenys has had an extensive career in the Australian Public Service at senior levels with responsibility for a number of significant government programs covering economic and social policy areas. She has more than 25 years’ experience in the public sector and began her career as a graduate in the Industry Commission.

Prior to her current role, Glenys was Secretary, Department of Industry, Innovation and Science (2013 – 2017) and Secretary of the Department of Regional Australia, Local Government, Arts and Sport (2010-2013). She has served as Deputy Secretary in the Department of the Prime Minister and Cabinet (2009-2010) and the Department of Families, Housing, Community Services and Indigenous Affairs (2002-2009).

Glenys has held a number of executive positions in the ACT Government including Deputy Chief Executive, Department of Disability, Housing and Community Services and Deputy CEO, Department of Health. She also held senior positions in housing, energy and utilities functions with the ACT Government.

Glenys was awarded a Public Service Medal in 2010 for coordinating Australian Government support during the 2009 Victorian bushfires. Glenys has an economics degree from the Australian National University and an MBA from the University of Canberra.


17

DR CHARLIE DAY

Chief Executive Officer Office of Innovation and Science Australia

A STRATEGIC OVERVIEW OF INNOVATION, SCIENCE AND RESEARCH IN AUSTRALIA’S HEALTH SECTOR

ABOUT CHARLIE Dr Day is the CEO of Innovation and Science Australia (ISA). He brings to the role significant expertise in innovation, business development, technology commercialisation, venture capital and start-up creation. As CEO, Dr Day leads the Office of Innovation and Science Australia and supports the Innovation and Science Australia (ISA) board’s implementation of long-term initiatives to boost Australia’s innovation, science and research system.

ISA provides strategic, whole-of-government advice on all science, research and innovation matters. In January 2018 ISA released the Australia 2030: Prosperity through Innovation report, which sets out a path for Australia to become a leading innovation nation by 2030.

Immediately prior to taking up his role with ISA, Dr Day was the Program Director for the Carlton Connect Initiative, an ambitious project to create Australia's premier STEM (Science, Technology, Engineering and Mathematics) innovation precinct anchored by the University of Melbourne.


18

PROFESSOR IAN FRAZER AC FRS FAA

President Australian Academy of Health and Medical Sciences

WHAT NEXT FOR THE MEDICAL RESEARCH FUTURE FUND?

ABOUT IAN Professor Ian Frazer is a clinician scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at TRI in Brisbane, Australia on the immunobiology of epithelial cancers. He is recognised as co-inventor of the technology enabling the HPV vaccines, currently used worldwide to help prevent cervical cancer. He heads a biotechnology company, Admedus Vaccines, working on new vaccine technologies, and is a board member of several companies and not for profit organisations. He is current president of the Australian Academy of Health and Medical Sciences, and a member of the Commonwealth Science Council. Most recently appointed chair of the Commonwealth Government’s Australian Medical Research Advisory Board (AMRAB) for the Medical Research Future Fund (MRFF).

He was recognised as Australian of the Year in 2006. He was recipient of the Prime Ministers Prize for Science, and of the Balzan Prize, in 2008, and was elected Fellow of the Royal Society of London in 2012.

He was appointed Companion of the Order of Australia in the Queen’s Birthday Honours list in 2013.


19

PROFESSOR DAVID VAUX AO FAA FAAHMS

Deputy Director Walter and Eliza Hall Institute of Medical Research

RESEARCH INTEGRITY AT MRIS: ISSUES AND RESPONSES

ABOUT DAVID Prof David Vaux is Deputy Director of The Walter and Eliza Hall Institute (WEHI). He graduated in medicine at Melbourne University, interrupted by a BMedSci year in Gus Nossal’s lab. After his intern year at the Royal Melbourne Hospital, he returned to WEHI to do a PhD, and then went to Stanford as a post-doctoral fellow. He returned to Australia in 1993. His research field is apoptosis/programmed cell death. He is a Fellow of the Australian Academy of Science and the Australian Academy of Health and Medical Sciences, and a member of The Center for Scientific Integrity, which acts as the board of Retraction Watch.


20

PROFESSOR RICKY JOHNSTONE

Executive Director Cancer Research

SIEGI SCHMIDMAIER

Executive Director of Strategy

Peter MacCallum Cancer Centre

FROM FUNDAMENTAL RESEARCH TO CLINICAL CARE – THE PETER MAC CELLULAR IMMUNOTHERAPY CASE STUDY

ABOUT RICKY Prof Ricky W. Johnstone is the Peter Mac Executive Director of Cancer Research (EDCR), University of Melbourne Head of the Sir Peter MacCallum Department of Oncology. Prof Johnstone is a cancer researcher who has utilized genetic mouse models of hemopoietic malignancies and solid tumors to understand the epigenetic changes that underpin tumor onset and progression and to develop new therapies that target epigenetic and transcriptional regulatory proteins. Prof Johnstone has recently discovered how epigenetic based-agents can engage the host immune system to drive prolonged therapeutic responses. Prof. Johnstone and his team are advancing these fundamental discoveries to clinical testing through the implementation of clinical trials that combine epigenetic and immunotherapeutic agents.

Prof Johnstone published a total of 227 papers with >25,000 total citations and a H-index of 74. As EDCR, his role is to strategically drive Peter Mac’s standing as one of the leading cancer centres in the world by enhancing its research outputs, building local, national and international collaborations, increasing its talent pool and enabling existing and new areas of research excellence to enhance the model of research-driven clinical care that serves as a cornerstone of Peter Mac’s mission.

ABOUT SIEGI Siegi is the Executive Director of Strategy at Peter MacCallum Cancer Centre where she is responsible for creating projects and business opportunities that introduce new technology, innovation and a commercial focus to the traditional hospital setting to improve patient outcomes.

Siegi has management and leadership responsibility for the Communications function and Pathology division, and is a Board Director for Cell Therapies P/L. She gained valuable experience as a senior policy adviser at the Department of Prime Minister and Cabinet, and since then she has worked in international health care consulting, hospital and medical research strategy, led cross functional teams and gained governance experience through Board Directorships. She has extensive experience in navigating complex projects, managing risks, stakeholders and political dynamics and enjoys new challenges.

In addition to her credentials in strategic positioning, policy development, complex project delivery and stakeholder management, she is a graduate of the Australian Institute of Company Directors, has a Master of Science (Public Health), a Bachelor of Nursing, and Graduate Diploma of Project Management.

63

NOTES

Association of Australian Medical Research Institutes

ABN 12 144 783 728

PO Box 2097 Royal Melbourne Hospital VIC 3050

[email protected] 03 9345 2500

www.aamri.org.au @AAMRI_Aus

2018 annual convention - aamri

Documents